• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Academy of Medical Royal Colleges not supporting Medical Innovation Bill

Academy of Medical Royal Colleges not supporting Medical Innovation Bill

January 23, 2015
CenterWatch Staff

The Academy of Medical Royal Colleges has released a statement on the proposed Medical Innovation Bill.

In a statement, the academy said, “The desire to promote innovation is fully supported by the medical profession and we welcome the opportunity that the Medical Innovation Bill has provided for this to be debated. However, the view of the Academy and Medical Royal Colleges, reaffirmed at the end of last year, is that we do not believe that the bill actually will achieve this worthwhile intention.”

According to the academy, when it was first presented, Royal Colleges and other professional medical bodies had concerns about potential unintended implications of the Bill. The academy does believe that the amendments made to the bill to date have addressed a number of those concerns.

“There still, however, remains a danger of the unintended consequences of the bill in diverting efforts away from properly conducted clinical research trials,” said the academy. “In addition, even as amended, we remain unclear as to what value the bill will add to the current position. We do not, therefore, believe that the legislation is necessary and efforts could more helpfully be directed at removing some of the practical barriers that can impede real innovation in the NHS.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing